AstraZeneca's ($AZN) MedImmune has licensed a toll-like receptor (TLR) agonist from 3M ($MMM), in the hopes that intratumoral injection of the candidate will allow ...
Morning Overview on MSN
Universal nasal spray vaccine could block COVID, flu, and pneumonia
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, ...
ST. PAUL, Minn. 3M Drug Delivery Systems will license its toll-like receptor agonist compounds to Celldex Therapeutics for an undisclosed sum under a licensing agreement announced Wednesday. Celldex ...
What’s in the Hollywood water that’s making so many celeb couples move to splitsville? We’re still reeling from the Angelina Jolie/Brad Pitt separation, and now actor Tobey Maguire and wife Jennifer ...
Leading compounder A. Schulman, Inc. is partnering with 3M to develop insulating and low-density compounds that incorporate engineered hollow glass microspheres marketed under the 3M Glass Bubbles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results